![](images/btn_header_register.jpg)
![](images/logo.gif)
Synopsis: An open access, peer reviewed electronic journal that covers human brain diseases and disorders.
Indexing: Pubmed indexing for NIH-funded research.
Processing time: Decision in 2 weeks for 90% of papers.
Visibility: Most popular article read 300+ times.
Aims and scope:
Journal of Brain Disease is an open access, peer-reviewed journal which covers all types of human brain diseases and disorders. Clinical practice, research, and education of brain disease science are emphasized. Adult and pediatric neurology, neurosurgery, neuroradiology, endovascular surgical neuroradiology, neuropsychiatry, neurophysiatry, neuropharmacology, neurophysiology, and neuropathology specialties are represented.
Manuscripts on epidemiology, pathology, diagnosis, prognosis, and management of all brain diseases are welcomed.
Editorial standards and procedures:
Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers. Reviewers are required to provide fair, balanced and constructive reports.
Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair. Appeals are considered by the Editor in Chief or Associate Editor.
Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.
National Institutes of Health Public Access Policy compliant:
As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.
If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf.
Call for papers:
The Editor in Chief welcomes submissions. Submissions of the following types are invited:
All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy. Copyright in published articles remains with the author(s). Authors are continually informed of the progress of their paper and our staff are friendly and responsive.
One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."
Criteria for publication:
Publication is dependent on peer reviewers' judgement of papers. Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility.
Previous work in the field must be acknowledged and papers should read without unreasonable difficulty. Papers should fit comfortably within the scope of the journal.
Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research. They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible.
More information on the role of peer reviewers is available on the information for reviewers page. Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.
Articles submitted to other journals:
We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication.
Services for authors:
Prior to peer review of your paper we can:
After peer review of your paper we can:
What other authors have said:
Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards. Here's what some recent authors have said about us:
"Within a couple of days the reviewers had been procured and the manuscript was out."
"The communication between your staff and me has been terrific. Whenever progress is made with the manuscript, I receive notice. Quite honestly, I've never had such complete communication with a journal."
"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."
Article processing fees:
All submissions to this journal are subject to an article processing fee if they are accepted for publication. Article processing fees are used to fund the processing of your paper and development of the journal. Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor. There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.
Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations. Authors must be able to verifiably demonstrate their suitability for a discount or waiver. Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion. Waivers and discounts must be applied for prior to submission. Neither are available after submission.
Register as a peer reviewer:
Do you wish to register as a peer reviewer? Or are you already a registered peer reviewer but you need to update your contact details? To register or update your details visit the peer reviewer registration form.
Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.
Peer reviewers are sought. Click here to apply or to update your details.
Check the Publisher's Blog for recent news
Dr. Bart M. Demaerschalk is an Associate Professor of Neurology at the Mayo Clinic College of Medicine, as well as a Consultant in the Divisions of Cerebrovascular Diseases and Critical Care Neurology, and Medical Director of the Cerebrovascular Diseases Center, Department of Neurology, Mayo Clinic Arizona. He is also Director of the STARR (Stroke Telemedicine for Arizona Rural Residents) network and the Mayo Clinic Hospital Joint Commission certified primary stroke center. Previously he consulted at St. Joseph’s Health Centre, University of Western Ontario, and Hotel Dieu Grace and Windsor Regional Hospitals in the province of Ontario, Canada, where he trained in neurology, vascular neurology, health research methodology, and medical education.
Dr. Demaerschalk has received numerous awards for excellence in clinical practice and neurological research. He belongs to over a dozen professional groups and organizations. He has taught and coordinated numerous courses and workshops at all levels and has, in turn, twice been designated the Mayo Clinic’s ‘Educator of the Year’ in 2003 and 2006. He has published over 60 peer-reviewed articles, editorials, letters, and textbook chapters and is the current recipient of ten government and industry grants for stroke research as Primary investigator. Dr. Demaerschalk is a very successful researcher, clinician, and educator with an excellent reputation both locally and internationally.